Genmab A/S
CSE:GMAB
Gross Margin
Genmab A/S
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | DK |
Market Cap | 126.2B DKK |
Gross Margin |
74%
|
Country | US |
Market Cap | 284.7B USD |
Gross Margin |
66%
|
Country | US |
Market Cap | 163.4B USD |
Gross Margin |
66%
|
Country | US |
Market Cap | 117.6B USD |
Gross Margin |
87%
|
Country | US |
Market Cap | 107.6B USD |
Gross Margin |
86%
|
Country | AU |
Market Cap | 135.3B AUD |
Gross Margin |
52%
|
Country | US |
Market Cap | 79.8B USD |
Gross Margin |
76%
|
Country | US |
Market Cap | 54.5B USD |
Gross Margin |
22%
|
Country | US |
Market Cap | 43.1B USD |
Gross Margin |
75%
|
Country | US |
Market Cap | 32.7B USD |
Gross Margin |
75%
|
Country | IE |
Market Cap | 26.6B USD |
Gross Margin |
75%
|
Profitability Report
View the profitability report to see the full profitability analysis for Genmab A/S.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Genmab A/S's most recent financial statements, the company has Gross Margin of 74.1%.